Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report)’s share price dropped 34.7% on Friday . The company traded as low as $5.05 and last traded at $5.05. Approximately 100 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 3,000 shares. The stock had previously closed at $7.7350.
Ascentage Pharma Group International Stock Down 34.7%
The stock has a 50 day moving average of $8.41 and a two-hundred day moving average of $8.56.
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.
Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.
Recommended Stories
- Five stocks we like better than Ascentage Pharma Group International
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
- Japan’s Stealth Bull Market: How U.S. Investors Can Get Exposure
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
